Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 1, Pages 686-689Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.02347-14
Keywords
-
Categories
Funding
- U.S. NIH NIAID [AI089688, AI099280]
- NIH grant [AI103947]
Ask authors/readers for more resources
Atovaquone is a component of Malarone, a widely prescribed antimalarial combination, that targets malaria respiration. Here we show that parasites with high-level resistance to an inhibitor of dihydroorotate dehydrogenase demonstrate unexpected atovaquone tolerance. Fortunately, the tolerance is diminished with proguanil, the second partner in Malarone. It is important to understand such genetic cross talk between respiration and pyrimidine biosynthesis since many antimalarial drug development programs target these two seemingly independent pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available